Xellia Pharmaceuticals, a company that manufactures specialty anti-infective treatments and critical care therapies, has been granted approval by the U.S. FDA for the manufacture of its first premix bag products at its facility in Cleveland, OH. Production has commenced and the first commercial batches have been released. Xellia has worked closely with the FDA to bring the Cleveland facility into operation, gaining approval for the commercial manufacturing of its first injectable drug product...